This consequently regulates the renal organic ion transporter expression, suppresses renal NLRP3 inflammasome activation, and provides the evidence for its use in the treatment of hyperuricemia and its associated kidney inflammation. The gene discussed is NLRP3; the disease is hyperuricemia.